New pills offer hope for Alzheimer’s sufferers
Anavex Life Sciences Reports Fiscal 2023 Year End Financial Results and Provides Business Update
Anavex Life Sciences to Announce Fiscal 2023 Year End Financial Results on Monday, November 27, 2023
Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73)
